Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment
Ole Skouvig Pedersen, Trine Ørhøj Barkholt, Stine Horskær Madsen, Frauke Rudolf
BMJ Case Reports · 2024-06
Abstract
We present the case of a patient with HIV and tuberculosis (TB) coinfection who initially developed paradoxical TB immune reconstitution inflammatory syndrome (TB-IRIS) post-antituberculous treatment and post-antiretroviral therapy initiation. Despite being managed effectively, lymphadenitis recurred as many as three times over the course of several years. Due to consistent culture-negative lymph node biopsies, the recurring lymphadenitis was eventually deemed inflammatory rather than microbiological recurrences. Cessation of anti-TB treatment led to symptom remission followed by a long asymptomatic period, corroborating the immunological nature of the episodes. However, 5 and 6 years after cessation of anti-TB treatment, respectively, lymphadenitis returned. In both instances, her symptoms regressed without treatment with anti-TB drugs. This case underscores the complexities of managing TB-IRIS and the necessity of differentiating between paradoxical TB-IRIS and other paradoxical reactions for appropriate treatment decisions. Recognition of such distinctions is crucial in guiding effective therapeutic interventions in TB-HIV coinfection scenarios.
MeSH terms
- Immune reconstitution inflammatory syndrome
- Medicine
- Tuberculosis
- Paradoxical reaction
- Asymptomatic
- Coinfection
- Tuberculous lymphadenitis
- IRIS (biosensor)
- Lymph node
- Dermatology
- Immunology
- Human immunodeficiency virus (HIV)
- Surgery